Ocugen (OCGN) Change in Acquisitions & Divestments (2017 - 2023)
Ocugen posted quarterly Change in Acquisitions & Divestments of $8.5 million for Q2 2023, down 5.56% on a QoQ basis from $9.0 million in Q1 2023.
Ocugen (OCGN) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $8.5 million in Q2 2023.
- For the quarter ending Q2 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2024 stood at $8.5 million (down 5.56% YoY), and the FY2023 full-year result was $17.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q2 2023 stood at $8.5 million, down from $9.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $9.0 million in Q1 2023 and bottomed at $8.5 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Mar 31, 2018 | 900,000.00 |
| Mar 31, 2018 | 900,000.00 |
| Dec 31, 2017 | 891,000.00 |
| Dec 31, 2017 | 891,000.00 |